Sruti Biswal

Employment

Employment history is unavailable.

Education

• National Institute of Technology Rourkela phD
  2023 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Targeting EGFR in cancer using Terminalia arjuna: An integrated In Silico, molecular dynamics, experimental validation, and network pharmacology study
  Computational Biology and Chemistry 2026 DOI: 10.1016/j.compbiolchem.2026.109336
  +Save
• Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer
  Computational Biology and Chemistry 2026 DOI: 10.1016/j.compbiolchem.2026.109211
  +Save
• KLF5-mediated transcriptional activation of miR-203a inhibits EMT and increases cisplatin sensitivity by targeting SNAI2 in tongue cancer
  Archives of Biochemistry and Biophysics 2026 DOI: 10.1016/j.abb.2026.110845
  +Save
• Cisplatin disrupts OCT1-DNMT1-piRNA epigenetic regulatory axis to suppress GAB2-mediated aggressiveness in OSCC
  Archives of Biochemistry and Biophysics 2026 DOI: 10.1016/j.abb.2026.110756
  +Save
• PLK1 inhibition by Shikonin attenuates oral cancer growth through β-catenin-mediated regulation of EMT and apoptosis
  Cellular Signalling 2026 DOI: 10.1016/j.cellsig.2025.112262
  +Save
• Silent Guardians Gone Rogue: The Role of PIWI and piRNA in Malignant Transformation
  IUBMB Life 2025 DOI: 10.1002/iub.70077
  +Save
• A piRNA chemosensitizes doxorubicin in tongue squamous cell carcinoma by targeting FDFT1 and inhibiting the EIF3H/HIF1α/CYPOR axis
  Archives of Biochemistry and Biophysics 2025 DOI: 10.1016/j.abb.2025.110455
  +Save
• Unlocking the potential of signature-based drug repurposing for anticancer drug discovery
  Archives of Biochemistry and Biophysics 2024 DOI: 10.1016/j.abb.2024.110150
  +Save
• miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response
  IUBMB Life 2024 DOI: 10.1002/iub.2786
  +Save